FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
复制标题
DOI:
10.1007/s00401-010-0698-6
复制
发表时间:
2010-07
影响因子:
12.7
通讯作者:
Isaacs AM
中科院分区:
文献类型:
--
作者:
Urwin H;Josephs KA;Rohrer JD;Mackenzie IR;Neumann M;Authier A;Seelaar H;Van Swieten JC;Brown JM;Johannsen P;Nielsen JE;Holm IE;FReJA Consortium;Dickson DW;Rademakers R;Graff-Radford NR;Parisi JE;Petersen RC;Hatanpaa KJ;White CL 3rd;Weiner MF;Geser F;Van Deerlin VM;Trojanowski JQ;Miller BL;Seeley WW;van der Zee J;Kumar-Singh S;Engelborghs S;De Deyn PP;Van Broeckhoven C;Bigio EH;Deng HX;Halliday GM;Kril JJ;Munoz DG;Mann DM;Pickering-Brown SM;Doodeman V;Adamson G;Ghazi-Noori S;Fisher EM;Holton JL;Revesz T;Rossor MN;Collinge J;Mead S;Isaacs AM
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-43)-negative frontotemporal lobar degeneration (FTLD) cases, and present here the first comprehensive analysis of these cases in terms of neuropathology, genetics, demographics and clinical data. 92% (34/37) had fused in sarcoma (FUS) protein pathology, indicating that FTLD-FUS is an important FTLD subtype. This FTLD-FUS collection specifically focussed on aFTLD-U cases, one of three recently defined subtypes of FTLD-FUS. The aFTLD-U subtype of FTLD-FUS is characterised clinically by behavioural variant frontotemporal dementia (bvFTD) and has a particularly young age of onset with a mean of 41 years. Further, this subtype had a high prevalence of psychotic symptoms (36% of cases) and low prevalence of motor symptoms (3% of cases). We did not find FUS mutations in any aFTLD-U case. To date, the only subtype of cases reported to have ubiquitin-positive but tau-, TDP-43- and FUS-negative pathology, termed FTLD-UPS, is the result of charged multivesicular body protein 2B gene (CHMP2B) mutation. We identified three FTLD-UPS cases, which are negative for CHMP2B mutation, suggesting that the full complement of FTLD pathologies is yet to be elucidated.
登录
查看更多内容
影响因子:
64.8
作者:
Cruts, Marc;Gijselinck, Ilse;Van Broeckhoven, Christine
通讯作者:
Van Broeckhoven, Christine
影响因子:
56.9
作者:
Kwiatkowski, T. J., Jr.;Bosco, D. A.;Brown, R. H., Jr.
通讯作者:
Brown, R. H., Jr.
影响因子:
6
作者:
Cairns, Nigel J.;Neumann, Manuela;Mackenzie, Ian R. A.
通讯作者:
Mackenzie, Ian R. A.
影响因子:
4.8
作者:
Knibb, Jonathan A.;Kipps, Christopher M.;Hodges, John R.
通讯作者:
Hodges, John R.
影响因子:
2.6
作者:
Luty, Agnes A.;Kwok, John B. J.;Thompson, Elizabeth M.;Blumbergs, Peter;Brooks, William S.;Loy, Clement T.;Dobson-Stone, Carol;Panegyres, Peter K.;Hecker, Jane;Nicholson, Garth A.;Halliday, Glenda M.;Schofield, Peter R.
通讯作者:
Schofield, Peter R.